Browsing by Subject "Opioid-Related Disorders"
Now showing items 1-20 of 46
-
Abuse and dependence on prescription opioids in adults: a mixture categorical and dimensional approach to diagnostic classification.
(Psychological medicine, 2011-03)For the emerging DSM-V, it has been recommended that dimensional and categorical methods be used simultaneously in diagnostic classification; however, little is known about this combined approach for abuse and dependence.Using ... -
Advances in opioid antagonist treatment for opioid addiction.
(The Psychiatric clinics of North America, 2012-06) -
Building a Group-Based Opioid Treatment (GBOT) blueprint: a qualitative study delineating GBOT implementation.
(Addiction science & clinical practice, 2019-12-27)BACKGROUND:Group-Based Opioid Treatment (GBOT) has recently emerged as a mechanism for treating patients with opioid use disorder (OUD) in the outpatient setting. However, the more practical "how to" components of successfully ... -
Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.
(Addiction (Abingdon, England), 2016-12)<h4>Aims</h4>To assess the safety of buprenorphine compared with methadone to treat pregnant women with opioid use disorder.<h4>Methods</h4>We searched PubMed, Embase and the Cochrane Library from inception to February 2015 ... -
Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.
(The American journal of psychiatry, 2011-07) -
Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.
(Current drug abuse reviews, 2012-03)Constant refinement of opioid dependence (OD) therapies is a condition to promote treatment access and delivery. Among other applications, the partial opioid agonist buprenorphine has been studied to improve evidence-based ... -
Construct and differential item functioning in the assessment of prescription opioid use disorders among American adolescents.
(Journal of the American Academy of Child and Adolescent Psychiatry, 2009-05)OBJECTIVE:To examine the psychometric properties of diagnostic criteria for prescription analgesic opioid use disorders (OUDs) and to identify background predictors of a latent continuum for OUD liability. METHOD:Data were ... -
Depressive symptoms, substance use, and HIV-related high-risk behaviors among opioid-dependent individuals: results from the Clinical Trials Network.
(Substance use & misuse, 2011-01)The sample included 343 opioid-dependent adults enrolled in two national multisite studies of the National Drug Abuse Treatment Clinical Trials Network (CTN001-002). Opioid-dependent individuals were recruited from 12 sites ... -
Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.
(Contemporary clinical trials, 2016-09)Substance use and its associated use disorders are under-detected and under-treated in primary care. There is a need for a clinically useful brief screening and assessment instrument to identify primary care patients with ... -
Development and validation of an electronic health records-based opioid use disorder algorithm by expert clinical adjudication among patients with prescribed opioids.
(Pharmacoepidemiology and drug safety, 2023-05)<h4>Background</h4>In the US, over 200 lives are lost from opioid overdoses each day. Accurate and prompt diagnosis of opioid use disorders (OUD) may help prevent overdose deaths. However, international classification of ... -
Differences in behavioral health disorders and unmet treatment needs between medical marijuana users and recreational marijuana users: Results from a national adult sample.
(Drug and alcohol dependence, 2017-11)BACKGROUND:Available data suggest that medical marijuana users may have more mental health problems than recreational marijuana users. There is limited information about differences in behavioral health disorders and unmet ... -
Discharge against medical advice from hospitalizations for substance use disorders: The potential impact of the Affordable Care Act.
(Drug and alcohol dependence, 2019-04)OBJECTIVES:To explore whether the Affordable Care Act (ACA) enactment is associated with changes in the proportion of discharge against medical advice (DAMA) among hospitalizations due to substance use disorders (SUDs). ... -
DSM-5 substance use disorders among adult primary care patients: Results from a multisite study.
(Drug and alcohol dependence, 2017-10)BACKGROUND:There are limited data about the extent of DSM-5 substance use disorders (SUDs) among primary care patients. METHODS:This study analyzed data from a multisite validation study of a substance use screening instrument ... -
Early outcomes following low dose naltrexone enhancement of opioid detoxification.
(The American journal on addictions, 2009-03)Although withdrawal severity and treatment completion are the initial focus of opioid detoxification, post-detoxification outcome better defines effective interventions. Very low dose naltrexone (VLNTX) in addition to methadone ... -
Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
(Journal of clinical psychopharmacology, 2007-10)BACKGROUND: The clinical use of naltrexone (NTX) in the treatment of opioid dependence has been limited because of poor compliance and inconsistent outcomes. In particular, the therapeutic benefit of extended treatment with ... -
Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults.
(General hospital psychiatry, 2013-01)OBJECTIVE:The objective was to identify a potential core set of brief screeners for the detection of individuals with a substance use disorder (SUD) in medical settings. METHOD:Data were from two multisite studies that evaluated ... -
Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial.
(Drug and alcohol dependence, 2014-05)The approval of extended release injectable naltrexone (XR-NTX; Vivitrol(®)) has introduced a new option for treating opioid addiction, but studies are needed to identify its place within the spectrum of available therapies. ... -
How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
(Journal of addiction medicine, 2011-03)To study substance use and psychiatric disorders among prescription opioid users, heroin users, and non-opioid drug users in a national sample of adults.Analyses of data from the 2001-2002 National Epidemiologic Survey on ... -
Illicit and nonmedical drug use among Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals.
(Drug and alcohol dependence, 2013-12)The racial/ethnic composition of the United States is shifting rapidly, with non-Hispanic Asian-Americans, Native Hawaiians/Pacific Islanders (NHs/PIs), and mixed-race individuals the fastest growing segments of the population. ... -
Impact of Spinal Cord Stimulation on Opioid Dose Reduction: A Nationwide Analysis.
(Neurosurgery, 2020-12)<h4>Background</h4>Opioid misuse in the USA is an epidemic. Utilization of neuromodulation for refractory chronic pain may reduce opioid-related morbidity and mortality, and associated economic costs.<h4>Objective</h4>To ...
